Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 5;59(Suppl5):v29-v38.
doi: 10.1093/rheumatology/keaa382.

Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors

Laurent Arnaud  1 , Maria G Tektonidou  2
Affiliations
Review

Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors

Laurent Arnaud et al. Rheumatology (Oxford). .

Abstract

SLE is a chronic autoimmune rheumatic disorder of high heterogeneity in clinical presentation, treatment response and prognosis. Long-term outcomes in SLE have been dramatically improved over the past decades, however, increased morbidity and mortality, especially among young individuals, still exists. Unmet needs include residual disease activity and frequent flares, glucocorticoid treatment dependency and toxicity, comorbidity burden, reduced health-related quality of life, health disparities and damage. The main determinants of long-term outcomes in SLE are age, sex, race/ethnicity, genetic profile, environmental factors including smoking, disease activity, major organ involvement such as lupus nephritis and CNS involvement, comorbidities including cardiovascular disease and serious infections, coexistence with APS, treatment adherence, socio-economic factors and access to care. In this review we discuss trends in long-term outcomes in SLE over the years and major contributors such as genetic, disease-related, treatment, comorbidity, socio-economic and other factors.

Keywords: SLE; comorbidities; damage; glucocorticoids; long-term outcomes; lupus nephritis; mortality; smoking; socio-economic factors; treatment adherence.

PubMed Disclaimer

Figures

<sc>Fig</sc>. 1
Fig. 1
Determinants of long-term outcomes in SLE
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Durcan L, O’Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 2019;393:2332–43. - PubMed
    1. Dörner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet 2019;393:2344–58. - PubMed
    1. Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 2017;76:2009–16. - PubMed
    1. Jorge AM, Lu N, Zhang Y, Rai SK, Choi HK. Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999–2014). Rheumatology (Oxford) 2018;57:337–44. - PMC - PubMed
    1. Felten R, Sagez F, Gavand P-E et al. 10 most important contemporary challenges in the management of SLE. Lupus Sci Med 2019;6:e000303. - PMC - PubMed

Publication types